Water → HCID 178481559, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[CH:9]([NH:14][C:15]([NH:19][C:20]3[C:29]4[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=4)[C:23]([N:30]4[CH2:35][CH2:34][O:33][CH2:32][CH2:31]4)=[CH:22][CH:21]=3)=[N:16][C:17]#[N:18])[N:8]=[C:7]([C:36]3[CH:41]=[CH:40][CH:39]=[CH:38][C:37]=3[Cl:42])[C:6]=2[CH:43]=1.O.FC(F)(F)C(O)=[O:48]>C1COCC1>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[CH:9]([NH:14]/[C:15](/[NH:19][C:20]3[C:29]4[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=4)[C:23]([N:30]4[CH2:31][CH2:32][O:33][CH2:34][CH2:35]4)=[CH:22][CH:21]=3)=[N:16]/[C:17]([NH2:18])=[O:48])[N:8]=[C:7]([C:36]3[CH:41]=[CH:40][CH:39]=[CH:38][C:37]=3[Cl:42])[C:6]=2[CH:43]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of N-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-N″-cyano-N′-[4-(4-morpholinyl)-1-naphthalenyl]guanidine (EXAMPLE 10) (21.9 mg, 35.8 μmol), water (4.6 μL, 260 μmol) and trifluoroacetic acid (19.8 μL, 257 μmol) in THF (3 mL) was heated to reflux for 43 h. The reaction was concentrated in vacuo, and the residue was purified by reverse phase HPLC (gradient 20-70% CH3CN in H2O) to provide the title compound (0.0092 g, 35%) as its TFA salt. 1H-NMR (CD3OD): δ 8.37 (br s, 1H), 8.06 (br s, 1H), 7.75-7.41 (br m, 9H), 7.26 (br s, 1H), 7.04 (br s, 1H), 5.66 (br s, 1H), 4.00 (br s, 4H), 3.58 (br s, 3H), 3.17 (br s, 4H). HRMS calculated for (C32H29Cl2N7O3+H) (M+H)+: 630.1787. Found (ESI): 630.1800.
Workup
- temperaturewas heated
- temperatureto reflux for 43 h
- concentrationThe reaction was concentrated in vacuo
- customthe residue was purified by reverse phase HPLC (gradient 20-70% CH3CN in H2O)
Sources & evidence
- ORD record
- ord-58662a94b1c64084a8bc0370490d7185
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07375101B2
Reaction notes
Loading…